Clinical Trials Directory

Trials / Completed

CompletedNCT03153020

Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône

Status
Completed
Phase
Study type
Observational
Enrollment
633 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The effectiveness of emergency management of acute ischemic stroke has improved considerably in recent years with thrombolysis and more recently thrombectomy. This improvement is accompanied by an increase in the number of stroke survivors. One of the major issues for these ever-increasing survivors is the prevention of recurrence. According to data from the 3 French registries, more than 20% of patients have at least one recurrence. Secondary prevention treatment has demonstrated his efficacy to prevent stroke recurrence. This evolution justifies identifying factors associated with adherence to secondary prevention treatment, measured at 1 year post-stroke / transient ischemic attack (TIA), in patients included in the STROKE 69 cohort.

Conditions

Interventions

TypeNameDescription
OTHERPatients with stroke or transient ischemic attackDetermination of factors associated to the conformity to secondary prevention treatment 1, 2 and 3 years post a stroke or transient ischemic attack.

Timeline

Start date
2017-09-11
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2017-05-15
Last updated
2025-11-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03153020. Inclusion in this directory is not an endorsement.

Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the R (NCT03153020) · Clinical Trials Directory